ODE Deputy Directors To Manage FDAMA & PDUFA II Responsibilities
Oncology Drug Products Division Deputy Director Robert Justice is serving as acting division director, following the departure of Robert DeLap, MD/PhD, to become Office of Drug Evaluation V deputy director.
You may also be interested in...
Genentech Senior Clinical Scientist Robert Justice, MD, is returning to FDA as director of the Division of Gastrointestinal & Coagulation Drug Products in September
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011